The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding
Crossref DOI link: https://doi.org/10.1007/s11239-020-02037-3
Published Online: 2020-01-10
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hanigan, Sarah http://orcid.org/0000-0003-4594-0496
Das, Jessica
Pogue, Kristen
Barnes, Geoffrey D.
Dorsch, Michael P.
Text and Data Mining valid from 2020-01-10
Version of Record valid from 2020-01-10
Article History
First Online: 10 January 2020